Latest News - Sirona Biochem http://sironabiochem.com Wed, 08 Sep 2010 22:32:04 +0100 FeedCreator 1.7.3 http://sironabiochem.com/images/M_images/joomla_rss.png http://sironabiochem.com Latest News - Sirona Biochem http://sironabiochem.com/index.php?option=com_content&task=view&id=49&Itemid= Sirona Biochem Signs Binding Preliminary Agreement to Acquire TFChem VANCOUVER, CANADA and ROUEN, FRANCE – August 25, 2010 – Sirona Biochem Corp. (TSX-V: SBM), a biotechnology company specializing in carbohydrate-based molecules, including therapeutics for diabetes and... Tue, 24 Aug 2010 21:44:39 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=19&Itemid= Sirona Biochem Closes Non-Brokered Private Placement January 29, 2010 VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on drug development for diabetes and obesity, announced today that it has arranged a non-brokered private... Fri, 29 Jan 2010 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=21&Itemid= Sirona Biochem Says Improved Chemical Process For Its Sugar Blocker Molecules Will Speed Up Pre-Clinical Development DECEMBER 8, 2009, VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on diabetes and obesity, announced... Tue, 08 Dec 2009 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=22&Itemid= Sirona Biochem Bolsters Scientific Advisory Board With Another Top Canadian Scientist. DECEMBER 7, 2009 ,VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on drug development for diabetes and obesity, announced today the... Mon, 07 Dec 2009 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=23&Itemid= Eminent Canadian Diabetes Scientist Joins Sirona Biochem’s Scientific Advisory Board. NOVEMBER 23, 2009 ,VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on drug development for diabetes and obesity, announced today another major... Mon, 23 Nov 2009 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=24&Itemid= Sirona Biochem Says New Results From Big Pharma Shows Why SGLT2 Sugar Blockers Are A Major Opportunity In Fighting Diabetes. NOVEMBER 17, 2009, VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on... Tue, 17 Nov 2009 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=25&Itemid= Sirona Biochem Ceo Says Diabetes Will Have ‘Profound Consequences’ For Canada As The Epidemic Strikes More Young People. NOVEMBER 12, 2009 ,VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM) CEO, Dr. Howard Verrico, says the threat of... Thu, 12 Nov 2009 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=26&Itemid= One Of Canada’s Leading Obesity Scientists Joins Sirona Biochem’s Scientific Advisory Board. NOVEMBER 5, 2009 ,VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on drug development for diabetes and obesity, announced today... Thu, 05 Nov 2009 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=27&Itemid= One Of Canada’s Leading Biotech Pioneers Joins Sirona Biochem’s Scientific Advisory Board. VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech drug development company focused on diabetes and obesity, announced today the appointment of Professor... Tue, 03 Nov 2009 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=28&Itemid= Sirona Biochem Says New Obesity Data Shows It’s On The Right Path October 13, 2009 VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on diabetes and obesity, says a newly released Dutch diabetes... Tue, 13 Oct 2009 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=29&Itemid= Sirona Biochem Adds French Patenting ‘Top Gun’ Lawyer To Its Scientific Advisory Board. September 29, 2009 VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on diabetes and obesity, announced today the first major... Tue, 29 Sep 2009 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=30&Itemid= Sirona Biochem To ‘Accelerate’ Drug Development After French Partner Opens State-Of-The-Art Lab. September 22, 2009 VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM) , an emerging biotech company focused on diabetes and obesity, announced today that it is... Tue, 22 Sep 2009 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=31&Itemid= Sirona Biochem Says SGLT Test Results Confirm Key ’Breakthrough’. September 14, 2009 VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on diabetes and obesity, says results of testing its unique SGLT inhibitor molecules... Mon, 14 Sep 2009 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=32&Itemid= Sirona Biochem Reports Drug Testing Proceeding ‘As Planned’ August 27, 2009 VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on diabetes and obesity, says critical testing of SGLT inhibitor molecules is proceeding as... Thu, 27 Aug 2009 08:00:00 +0100 http://sironabiochem.com/index.php?option=com_content&task=view&id=33&Itemid= Sirona Biochem Receives Financial Contribution From NRC-IRAP August, 13, 2009, VANCOUVER, CANADA: Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech company focused on diabetes and obesity drug development, announced today that it has received a financial... Mon, 03 Aug 2009 08:00:00 +0100